4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-17-009529
CIK 0001566373operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:10 PM ET
Size
5.5 KB
Accession
0001209191-17-009529
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-09+40,000→ 40,000 totalExercise: $7.66Exp: 2027-02-09→ Cpmmon Stock (40,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 9, 2017, with 25% of the shares subject to the option vesting on January 1, 2018 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:10 PM ET
- Size
- 5.5 KB